About Fermentek
Fermentek is a Healthcare company based in Jerusalem (Israel) founded in 1994 by Yosef Behrend. It develops and supplies biochemicals for scientific research and safety testing globally. It operates on a B2B model. Its chief executive is Yosef Behrend. Fermentek offers products and services including Mycotoxins, Antibiotics, and Standard Solutions. Its focus areas include Life Sciences, Biochemicals, Research Compounds and Mycotoxins. Its legal entity is FERMENTEK Ltd. Similar companies include GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics and 5 more; 9 of its 10 listed similar companies have raised funding.
Company details
Fermentek is a global leader in the research, development, and production of fine biochemicals, including Mycotoxins and Antibiotics. Based in Jerusalem, Israel, they provide high-quality products to scientists, researchers, and distributors. Their offerings support life science research, food safety testing, and water safety applications through bulk orders and personalized services. They ensure immediate worldwide delivery and focus on quality assurance for various sectors.
- Headquarters Jerusalem, Israel
- Founders Yosef Behrend
- SectorsHealthcare
- Phone•••• ••••
- Website fermentek.com
- Social LinkedIn Facebook
- Legal Name Fermentek Ltd
Products & Services of Fermentek
Fermentek offers a comprehensive portfolio of products and services, including Mycotoxins, Antibiotics, and Standard Solutions.
Compounds for research and safety testing applications
Natural products used in scientific and medical research
Solutions for food and water safety analysis
People of Fermentek
1 people are tracked at Fermentek (1 in leadership).
| Name | Role | Group |
|---|---|---|
Yosef Behrend | Founder, CEO | Leadership |
Complete people profiles for Fermentek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Fermentek
Fermentek has 10 listed similar companies in our database, 9 of them funded. They include GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed similar companies of Fermentek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fermentek
The website of Fermentek (fermentek.com) receives about 6.6K visits a month.
- Monthly visits6.6K
▲ 47% vs previous month
Websites whose visitors overlap most with Fermentek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| qualitybiological.com | 78% | 5.9K | #3,332,912 | View details |
Top companies in Toxicology
10 companies that operate in the same segment as Fermentek (Toxicology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | – | – | |
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | – | – | |
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 | |
Non-invasive drug testing technology is developed using fingerprints. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 25.71 M | – | – | |
Provides toxicology, chemistry, and consultancy services for agrochemical industries. | 2020 | Vapi, Gujarat, India | – | – | – | |
Instruments for rapid human DNA identification are developed. | 2006 | Pleasanton, California, United States | USD 92.06 M | USD 22.5 B | 78 | |
Oral therapies for snake bite treatment are developed. | 2015 | Corte Madera, California, United States | USD 16.48 M | – | – | |
Quantitative urine drug testing is provided for patient monitoring. | 2011 | San Diego, California, United States | – | – | 358 | |
Point-of-care platforms for heavy metal toxicity diagnostics are developed. | 1968 | Billerica, Massachusetts, United States | USD 34 M | – | – | |
Real-time trace gas analysis solutions are delivered using SIFT-MS technology. | 2002 | Christchurch, New Zealand | USD 11.9 M | USD 23.52 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fermentek
Fermentek was founded in 1994.
Fermentek is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Yosef Behrend is the current CEO of Fermentek. They have also founded this company.
Fermentek is a global leader in the research, development, and production of fine biochemicals, including Mycotoxins and Antibiotics. Based in Jerusalem, Israel, they provide high-quality products to scientists, researchers, and distributors. Their offerings support life science research, food safety testing, and water safety applications through bulk orders and personalized services. They ensure immediate worldwide delivery and focus on quality assurance for various sectors.
Fermentek's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Fermentek offers Mycotoxins, Antibiotics, and Standard Solutions.
Fermentek operates through Fermentek Ltd.